CG
RNXT icon

Caprock Group’s RenovoRx RNXT Stock Holding History

Caprock Group’s Portfolio RNXT Stock Details RNXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62.7K Hold
63,940
– – ﹤0.01% 1216
2026
Q1 		$64.6K Hold
63,940
– – ﹤0.01% 1096
2025
Q4 		$53.7K Buy
+63,940
New +$64K ﹤0.01% 1175

Other funds holding RNXT

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

Caprock Group's RNXT Position: Q2 2026 in Review

Caprock Group held its RenovoRx (RNXT) position steady in Q2 2026 at 63,940 shares worth $62.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1216.

Caprock Group first reported a position in RNXT in Q4 2025 and has held it in 3 quarters since. The position peaked at $64.6K in Q1 2026. 28 funds tracked by Wall St. Rank hold RNXT as of Q2 2026.

  • Caprock Group held 63,940 shares of RenovoRx worth $62.7K as of Q2 2026.
  • Caprock Group left its RenovoRx share count unchanged in Q2 2026.
  • RenovoRx made up ﹤0.01% of Caprock Group's portfolio in Q2 2026, its #1216 holding.
  • Caprock Group first reported a position in RenovoRx in Q4 2025 and has held it in 3 quarters since.
  • Caprock Group's RenovoRx position peaked at $64.6K in Q1 2026.
  • 28 funds tracked by Wall St. Rank held RenovoRx as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.